Sanofi Chief Signals Focus On Cancer With $2.5 Billion Deal

0
173
Sanofi Chief Signals Focus On Cancer With $2.5 Billion Deal

Sanofi SA has agreed to buy cancer biotech company Synthorx Inc. for $2.5 billion, the first big move by new Chief Executive Paul Hudson to reinvigorate the sprawling French health care giant.
The company has a long history in cancer-drug development but has…
Read More

LEAVE A REPLY

Please enter your comment!
Please enter your name here